We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group

News   Feb 13, 2019 | Original story by Sara Reardon for Nature

 
Antidepressant Based on Ketamine Gets Backing From FDA Advisory Group

Credit: Pixabay

 
 
 

RELATED ARTICLES

Preventing the Spread of Certain Cancers

News

Scientists have taken an important step towards the development of an agent against the metastasis of certain cancers.

READ MORE

Tech Behind Bitcoin Could Improve Medications of the Future

News

Researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

READ MORE

Studying Cells’ “Self-eating” Could Help Create New Dementia Drugs

News

A team from the University of Plymouth has shed light on the mechanisms behind cell "self-eating" and how it progresses. They hope that this information could be used to direct efforts towards new treatment for dementia.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE